• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

组织激肽释放酶-激肽系统在人肾上腺中的表达及细胞定位

Expression and cellular localization of tissue kallikrein-kinin system in human adrenal gland.

作者信息

Wang D Z, Song Q, Chen L M, Chao L, Chao J

机构信息

Department of Biochemistry and Molecular Biology, Medical University of South Carolina, Charleston 29425, USA.

出版信息

Am J Physiol. 1996 Sep;271(3 Pt 2):F709-16. doi: 10.1152/ajprenal.1996.271.3.F709.

DOI:10.1152/ajprenal.1996.271.3.F709
PMID:8853434
Abstract

The tissue kallikrein-kinin system has been implicated in regulating blood pressure and electrolyte homeostasis. To understand the function of this system, we identified the expression and cellular localization of its components including tissue kallikrein, kallistatin, kininogen, and bradykinin B1 and B2 receptors in human adrenal gland. Reverse transcription-polymerase chain reaction followed by Southern blot analysis showed that these five components of this system were all expressed in human adrenal gland. In situ hybridization histochemistry with respective digoxigenin-labeled antisense riboprobes revealed localization of kallikrein transcript throughout the adrenal cortex and medulla except the zona glomerulosa, whereas kallistatin mRNA was only localized in the zona fasciculata. Low-molecular-weight kininogen and B2 receptor mRNAs were colocalized in the zona glomerulosa and zona fasciculata and also in the zona reticularis and chromaffin cells but to a lesser degree. The B1 receptor mRNA was stained in the zona fasciculata and medulla. These results show the expression and differential colocalization of the components of the tissue kallikrein-kinin system and reveal the potential action sites of this system in the adrenal gland.

摘要

组织激肽释放酶 - 激肽系统与血压调节和电解质平衡有关。为了解该系统的功能,我们确定了其组分包括组织激肽释放酶、激肽释放酶抑制蛋白、激肽原以及缓激肽B1和B2受体在人肾上腺中的表达及细胞定位。逆转录 - 聚合酶链反应后进行Southern印迹分析表明该系统的这五个组分在人肾上腺中均有表达。用各自地高辛标记的反义核糖探针进行原位杂交组织化学显示,激肽释放酶转录本除在球状带外遍布肾上腺皮质和髓质,而激肽释放酶抑制蛋白mRNA仅定位于束状带。低分子量激肽原和B2受体mRNA在球状带和束状带中共同定位,在网状带和嗜铬细胞中也有共同定位,但程度较低。B1受体mRNA在束状带和髓质中呈阳性染色。这些结果显示了组织激肽释放酶 - 激肽系统组分的表达及差异共定位,并揭示了该系统在肾上腺中的潜在作用位点。

相似文献

1
Expression and cellular localization of tissue kallikrein-kinin system in human adrenal gland.组织激肽释放酶-激肽系统在人肾上腺中的表达及细胞定位
Am J Physiol. 1996 Sep;271(3 Pt 2):F709-16. doi: 10.1152/ajprenal.1996.271.3.F709.
2
Expression and cellular localization of the kallikrein-kinin system in human ocular tissues.激肽释放酶-激肽系统在人眼组织中的表达及细胞定位
Exp Eye Res. 1996 Jul;63(1):19-26. doi: 10.1006/exer.1996.0087.
3
Cellular localization of low-molecular-weight kininogen and bradykinin B2 receptor mRNAs in human kidney.人肾中低分子量激肽原和缓激肽B2受体mRNA的细胞定位
Am J Physiol. 1996 Jun;270(6 Pt 2):F919-26. doi: 10.1152/ajprenal.1996.270.6.F919.
4
Identification and occurrence of mRNAs for components of the kallikrein-kinin system in human skin and in skin diseases.人皮肤及皮肤疾病中激肽释放酶-激肽系统各组分mRNA的鉴定与表达情况
Immunopharmacology. 1999 Sep;43(2-3):287-91. doi: 10.1016/s0162-3109(99)00100-9.
5
Cellular localization of tissue kallikrein and kallistatin mRNAs in human kidney.组织激肽释放酶和激肽抑制蛋白mRNA在人肾脏中的细胞定位
Kidney Int. 1995 Sep;48(3):690-7. doi: 10.1038/ki.1995.339.
6
Expression of kininogen, kallikrein and kinin receptor genes by rat cardiomyocytes.大鼠心肌细胞中激肽原、激肽释放酶和激肽受体基因的表达
Biochim Biophys Acta. 2000 Jan 10;1495(1):69-77. doi: 10.1016/s0167-4889(99)00154-8.
7
Localization and expression of tissue kallikrein and kallistatin in human blood vessels.
J Histochem Cytochem. 1999 Feb;47(2):221-8. doi: 10.1177/002215549904700210.
8
Expressions of bradykinin B2-receptor, kallikrein and kininogen mRNAs in the heart are altered in pressure-overload cardiac hypertrophy in mice.
Biol Pharm Bull. 2001 Jan;24(1):34-8. doi: 10.1248/bpb.24.34.
9
Cellular localization of kallistatin and tissue kallikrein in human pancreas and salivary glands.人胰腺和唾液腺中激肽释放酶抑制蛋白和组织激肽释放酶的细胞定位
Histochem Cell Biol. 1998 Nov;110(5):477-84. doi: 10.1007/s004180050309.
10
Lipopolysaccharide activates the kallikrein-kinin system in mouse choroid plexus cell line ECPC4.脂多糖激活小鼠脉络丛细胞系ECPC4中的激肽释放酶-激肽系统。
Neurosci Lett. 2008 Apr 4;434(3):310-4. doi: 10.1016/j.neulet.2008.01.072. Epub 2008 Feb 6.

引用本文的文献

1
Kallistatin deficiency exacerbates neuronal damage after cardiac arrest.卡列他汀缺乏症加剧心脏骤停后的神经元损伤。
Sci Rep. 2024 Feb 21;14(1):4279. doi: 10.1038/s41598-024-54415-z.
2
Delivery of recombinant adeno-associated virus-mediated human tissue kallikrein for therapy of chronic renal failure in rats.重组腺相关病毒介导的人组织激肽释放酶用于大鼠慢性肾衰竭治疗的递送
Hum Gene Ther. 2008 Apr;19(4):318-30. doi: 10.1089/hum.2007.138.
3
A synthetic tissue kallikrein inhibitor suppresses cancer cell invasiveness.一种合成组织激肽释放酶抑制剂可抑制癌细胞的侵袭性。
Am J Pathol. 2001 Nov;159(5):1797-805. doi: 10.1016/S0002-9440(10)63026-X.